Cordlife owns the largest network of cord blood banks in Asia with full stem cell banking facilities in six key markets, namely Singapore, Hong Kong, Indonesia, India, Malaysia and the Philippines. In Singapore, Hong Kong, the Philippines and Indonesia, Cordlife operates the largest private cord blood banks and it is amongst the top three market leaders in India and Malaysia. In January 2018, Cordlife became the market leader in Hong Kong with the acquisition of the largest private cord blood bank, Healthbaby Biotech (Hong Kong) Co., Limited. Through its majority-owned subsidiary in Malaysia, Stemlife Berhad, Cordlife holds an indirect stake in Thailand's largest private cord blood bank, Thai Stemlife. Cordlife has also established its presence in Myanmar, Vietnam, Macau, Brunei and Bangladesh.

Health Diagnostics

Life Sciences

Health Care

Biotechnology

Cordlife Group Limited

Shane Chua

Arvin C. Faundo

Kevin K.w. Chik

Elaine Ng

Chiew Yoke Fong

Leung Ho Chuen

Zhu Peng Cheng

The Medical Affairs Team at Cordlife Group Limited is responsible for ensuring the scientific integrity and clinical relevance of the company's stem cell banking services. This team collaborates with healthcare professionals and regulatory bodies, provides education and training on stem cell technology, and oversees the development of clinical guidelines and research initiatives. By bridging medical expertise with operational practices, they enhance patient care and support the company's commitment to advancing stem cell therapies across Asia.

Medical Affairs Team

Medical Affairs Team

About

Team members